KENNEDY CAPITAL MANAGEMENT LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 24 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2020$577,000
+50.3%
149,151
+47.1%
0.02%
+54.5%
Q2 2020$384,000101,3870.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders